Seven Eight Capital, LP Abb Vie Inc. Transaction History

Seven Eight Capital, LP

$1.05 Billion
Q3 2024

A detailed history of Seven Eight Capital, LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Seven Eight Capital, LP holds 15,860 shares of ABBV stock, worth $2.85 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

15,860

Previous 3,081 414.77%

Holding current value

$2.85 Million

Previous $528,000 493.18%

% of portfolio

0.3%

Previous 0.06%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $2.09 Million - $2.55 Million	12,779 Added 414.77%	15,860 $3.13 Million
Q2 2024 Aug 12, 2024	SELL	$154.79 - $180.76 $12,847 - $15,003	-83 Reduced 2.62%	3,081 $528,000
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $505,670 - $576,164	3,164 New	3,164 $576,000
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $4.51 Million - $5.22 Million	-33,739 Reduced 69.7%	14,665 $2.19 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $6.41 Million - $7.98 Million	48,404 New	48,404 $6.52 Million
Q2 2022 Aug 04, 2022	SELL	$137.62 - $174.96 $2.36 Million - $3.01 Million	-17,183 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$131.98 - $163.75 $1.26 Million - $1.56 Million	9,533 Added 124.61%	17,183 $2.79 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $496,648 - $628,404	4,623 Added 152.73%	7,650 $1.04 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $1.73 Million - $1.96 Million	-16,226 Reduced 84.28%	3,027 $327,000
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $2.03 Million - $2.26 Million	19,253 New	19,253 $2.17 Million
Q4 2020 Feb 09, 2021	SELL	$80.49 - $108.67 $548,378 - $740,368	-6,813 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $585,304 - $686,954	6,813 New	6,813 $597,000
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $2.29 Million - $3.47 Million	-35,473 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $2.56 Million - $3.2 Million	35,473 New	35,473 $3.14 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $13 Million - $15.6 Million	-205,958 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$65.7 - $83.98 $12.4 Million - $15.9 Million	189,200 Added 1129.01%	205,958 $15 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $1.29 Million - $1.52 Million	16,758 New	16,758 $1.35 Million
Q3 2018 Oct 18, 2018	SELL	$88.91 - $98.84 $7.26 Million - $8.07 Million	-81,658 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$89.78 - $106.23 $4.28 Million - $5.07 Million	-47,700 Reduced 36.87%	81,658 $7.57 Million
Q1 2018 May 14, 2018	BUY	$92.01 - $123.21 $11.9 Million - $15.9 Million	129,358 New	129,358 $12.2 Million
Q4 2017 Feb 12, 2018	SELL	$89.56 - $98.21 $7.6 Million - $8.33 Million	-84,858 Closed	0 $0
Q3 2017 Oct 16, 2017	BUY	$69.85 - $89.22 $5.2 Million - $6.64 Million	74,400 Added 711.42%	84,858 $7.54 Million
Q2 2017 Aug 10, 2017	BUY	N/A	10,458	10,458 $758,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.

Account

Seven Eight Capital, LP Abb Vie Inc. Transaction History